XML 90 R70.htm IDEA: XBRL DOCUMENT v3.22.1
Shareholders' Equity (Details) - Schedule of share-based compensation expenses - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Schedule of share-based compensation expenses [Abstract]      
Cost of revenue $ 51
Research and development 3,248 3,384 661
Sales and Marketing [1] 2,442 9,252 617
General and administrative 13,065 12,145 14,967
Share-based compensation expenses $ 18,806 $ 24,781 $ 16,245
[1] On October 26, 2020, the Company entered into an amendment to a business development agreement (“the Agreement”) dated February 4, 2020 with two service providers pursuant to which the Company paid an aggregate one-time payment of $400 thousand plus VAT and issued to them warrants to purchase an aggregate of 650,000 ordinary shares at an exercise price of $18 per share with a graded vesting ending 10 weeks following the grant date (subject to a standard cashless exercise provision). As a result, the Company recorded an expense of $6.1 million for the warrants granted. The service providers waived any and all past, present and future compensation to which they are or may be entitled pursuant to the Agreement and all activities undertaking on behalf of the Company, including the right to a percentage from future revenues from any of the Company’s systems and the issuance of warrants.